For a new cloning project, we needed to access the plasmid maps of an old construct of mine (pSecTagN2, which was a precursor of pMosaic, aka pSecTagI) which I had composed from many different sources in 1999.

Almost 30 years after starting my academic career, I started to teach at the Faculty of Pharmacy (without much pedagogic experience and education).

We have just published our latest review about the role of KLK3 as an activator of VEGF-C and VEGF-D in prostate cancer. Prostate cancer is one of the most common cancers in males. It is not a question whether you will get it but only when.